Ace Therapeutics offers comprehensive preclinical assessment services to support the discovery and development process of antipsychotic drugs. Our services include in vivo and in vitro pharmacology studies, as well as safety assessments. With our experienced preclinical development team, we can ensure that our clients receive comprehensive and reliable data support.
In vivo efficacy testing is designed to evaluate the pharmacological activity and mechanism of action of candidate compounds and provide data support for subsequent pharmacodynamic and safety studies. Our experienced researchers can select the appropriate cell model according to the client's demands and provide high-quality testing services.
Ace Therapeutics employs animal disease models to assist clients in evaluating the pharmacological activity and therapeutic effects of candidate compounds. Our experienced scientists will customize precise pharmacological models to your needs and conduct comprehensive in vivo pharmacodynamic testing to evaluate the therapeutic potential of candidate compounds.
Ace Therapeutics provides comprehensive pharmacokinetic analysis services to help clients study the absorption, distribution, metabolism and excretion of their antipsychotic drug candidates. Using customized experimental designs and advanced analytical techniques, we help our clients to accurately measure the changes of compounds in blood and tissue samples over time, and to fully predict the dynamic characteristics of compounds in vivo.
Our toxicology assessment services can assist you in assessing the safety of candidate compounds and identifying potential risks. Our state-of-the-art animal models and pharmacological knowledge enable us to comprehensively assess the acute and chronic toxicity, organ toxicity, developmental and reproductive toxicity, genotoxicity, and carcinogenicity of your candidate compounds. Our advanced analytical techniques and extensive experience ensure that you receive reliable toxicological data.
Ace Therapeutics offers professional abuse and dependence testing services for antipsychotic drug candidates. Our services utilize behavioral experiments, such as self-administration, conditioned taste aversion, and other behavioral experiments, to comprehensively assess the risk of addictive properties of compounds in the therapeutic dose range. Our high-quality testing and reliable data analysis provide a solid basis for your subsequent clinical trial design and regulatory oversight.
We recognize that every drug development project is distinct, and we provide highly customized testing solutions to meet your specific drug development demands.
We employ a variety of analytical techniques, including high-throughput screening, neuroimaging analysis, electrophysiology analysis, and mass spectrometry, to provide our clients with reliable data and to save them valuable time and resources.
Our extensive experience in model development allows us to develop and validate preclinical pharmacological models according to our clients' demands, helping them accurately assess the potential of their antipsychotic drug candidates.
Ace Therapeutics is committed to providing comprehensive and reliable preclinical testing services to assist you in making informed decisions regarding the development of antipsychotic drugs, thereby optimizing your chances of clinical success. If you are interested, please feel free to contact us and we will be happy to serve you.
Enter your E-mail and receive the latest news from us